Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver.
For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.
Table of Contents
1. Executive Summary
2. The Market Opportunity
2. Injectable Drug Device Summaries
3. Selected Product Specific Autoinjectors (8 Devices Analyzed)
4. Commercial Pen Injector Products (23 Devices Analyzed)
5. Wearable Devices - Analysis and Assessments
6. Emerging Technology
7. Market Factors
Companies Mentioned
- Tonghu Dongbao Pharmaceutical
- Ypsomed
- Desitronic
- Roche
- West Pharmaceutical
- Daikyo
- Terumo Europe NV
- Kyowa Hakko Kirin
- Motan
- Krauss Maffei
- Engel
- Netstal
- SHL Medical
- PA Consulting
- Owen Mumford
- Amgen
- Midas Pharma
- Elcam
- MedNet GmbH
- Recipharm
- Consort Medical
- Bespak
- BD Bioscience
- BD Diagnostics
- BD Medical
- Lilly
- Nycomed
- Schering AG
- Teva
- Bayer Healthcare
- EMD Serono
- Pfizer
- Chugai
- Immunex
- Wyeth
- Insulet
- Harro Hofliger
- Merck Serono
- NPS Pharma
- Vetter
- Haselmeier
- Nycomed
- Novo Nordisk
- Biogen
- GSK
- AstraZeneca
- Wockhardt
- Hollister-Stier
- Sanofi
- Sanofi Aventis Deutschlang
- Merck Serono
- Sandoz
- Becton Dickinson
- Genentech
- Antares Pharma
- Medac Pharma
- Oncotec Pharma
- Roche
- AMAG Pharmaceuticals
- Novartis
- Centocor
- Janssen Biotech
- Bayer Healthcare
- Dr. Reddy's
- US Worldmeds
- Meridian Medical
- Merck Serono
- Boehringer Ingelheim
- Swedish Orphan Biovitrum
- Valeant Pharmaceuticals
- Mylan Pharmaceuticals
- Samsung Bioepis
- GlaxoSmithKline
- Abbvie
